- Home
- MREO vs GHI Comparison
MREO vs GHI Comparison
Compare MREO & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- GHI
- Stock Information
- Founded
- MREO 2015
- GHI 1998
- Country
- MREO United Kingdom
- GHI United States
- Employees
- MREO N/A
- GHI N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- MREO Health Care
- GHI Finance
- Exchange
- MREO Nasdaq
- GHI Nasdaq
- Market Cap
- MREO 281.6M
- GHI 254.1M
- IPO Year
- MREO N/A
- GHI N/A
- Fundamental
- Price
- MREO $1.76
- GHI $10.85
- Analyst Decision
- MREO Strong Buy
- GHI Strong Buy
- Analyst Count
- MREO 5
- GHI 4
- Target Price
- MREO $7.40
- GHI $14.88
- AVG Volume (30 Days)
- MREO 932.9K
- GHI 44.7K
- Earning Date
- MREO 11-11-2025
- GHI 11-05-2025
- Dividend Yield
- MREO N/A
- GHI 13.66%
- EPS Growth
- MREO N/A
- GHI N/A
- EPS
- MREO N/A
- GHI N/A
- Revenue
- MREO $500,000.00
- GHI $27,326,828.00
- Revenue This Year
- MREO N/A
- GHI $223.15
- Revenue Next Year
- MREO $55.50
- GHI $5.11
- P/E Ratio
- MREO N/A
- GHI N/A
- Revenue Growth
- MREO N/A
- GHI N/A
- 52 Week Low
- MREO $1.47
- GHI $10.12
- 52 Week High
- MREO $4.72
- GHI $14.51
- Technical
- Relative Strength Index (RSI)
- MREO 48.66
- GHI 51.80
- Support Level
- MREO $1.68
- GHI N/A
- Resistance Level
- MREO $1.88
- GHI $10.90
- Average True Range (ATR)
- MREO 0.07
- GHI 0.20
- MACD
- MREO 0.01
- GHI -0.38
- Stochastic Oscillator
- MREO 45.45
- GHI 98.37
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.